Genomic and Epigenomic Biomarkers of Toxicology and Disease. Группа авторов

and Tewari, M. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 108: 5003–5008.

      3 Ashley, J., Cordy, B., Lucia, D., Fradkin, L.G., Budnik, V., and Thomson, T. (2018). Retrovirus-like Gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell 172 (262–274): e11.

      4 Bailey, W.J. and Glaab, W.E. (2018). Accessible miRNAs as novel toxicity biomarkers. Int. J. Toxicol. 37: 116–120.

      5 Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K., and Szabo, G. (2012). Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946–1957.

      6 Balansky, R., Longobardi, M., Ganchev, G., Iltcheva, M., Nedyalkov, N., Atanasov, P., Toshkova, R., De Flora, S., and Izzotti, A. (2013). Transplacental clastogenic and epigenetic effects of gold nanoparticles in mice. Mutat. Res. 751–752: 42–48.

      7 Balasubramanian, S., Gunasekaran, K., Sasidharan, S., Jeyamanickavel Mathan, V., and Perumal, E. (2020). MicroRNAs and xenobiotic toxicity: An overview. Toxicol. Rep. 7: 583–595.

      8 Beck, R., Bommarito, P., Douillet, C., Kanke, M., Del Razo, L.M., Garcia-Vargas, G., Fry, R.C., Sethupathy, P., and Styblo, M. (2018). Circulating miRNAs associated with arsenic exposure. Environ. Sci. Technol. 52: 14487–14495.

      9 Beezhold, K., Liu, J., Kan, H., Meighan, T., Castranova, V., Shi, X., and Chen, F. (2011). miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol. Sci. 123: 411–420.

      10 Bleck, B., Grunig, G., Chiu, A., Liu, M., Gordon, T., Kazeros, A., and Reibman, J. (2013). MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells. J. Immunol. 190: 3757–3763.

      11 Bollati, V., Angelici, L., Rizzo, G., Pergoli, L., Rota, F., Hoxha, M., Nordio, F., Bonzini, M., Tarantini, L., Cantone, L., Pesatori, A.C., Apostoli, P., Baccarelli, A.A., and Bertazzi, P.A. (2015). Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells. J. Appl. Toxicol. 35: 59–67.

      12 Bollati, V., Marinelli, B., Apostoli, P., Bonzini, M., Nordio, F., Hoxha, M., Pegoraro, V., Motta, V., Tarantini, L., Cantone, L., Schwartz, J., Bertazzi, P.A., and Baccarelli, A. (2010). Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ. Health Perspect. 118: 763–768.

      13 Bonneau, E., Neveu, B., Kostantin, E., Tsongalis, G.J., and De Guire, V. (2019). How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC 30: 114–127.

      14 Brunetto, M.R., Cavallone, D., Oliveri, F., Moriconi, F., Colombatto, P., Coco, B., Ciccorossi, P., Rastelli, C., Romagnoli, V., Cherubini, B., Teilum, M.W., Blondal, T., and Bonino, F. (2014). A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection. PLoS One 9: e110782.

      15 Buschmann, D., Kirchner, B., Hermann, S., Marte, M., Wurmser, C., Brandes, F., Kotschote, S., Bonin, M., Steinlein, O.K., Pfaffl, M.W., Schelling, G., and Reithmair, M. (2018). Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. J. Extracell Vesicles 7: 1481321.

      16 Bushel, P.R., Caiment, F., Wu, H., O’Lone, R., Day, F., Calley, J., Smith, A., and Li, J. (2018). RATEmiRs: The rat atlas of tissue-specific and enriched miRNAs database. BMC Genom. 19: 825.

      17 Cave, M.C., Pinkston, C.M., Rai, S.N., Wahlang, B., Pavuk, M., Head, K.Z., Carswell, G.K., Nelson, G.M., Klinge, C.M., Bell, D.A., Birnbaum, L.S., and Chorley, B.N. (2022). Circulating microRNAs, polychlorinated biphenyls, and environmental liver disease in the Anniston Community Health Survey. Environ. Health Perspect 101: 17003.

      18 Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6: e23937.

      19 Chakraborty, C., Sharma, A.R., Sharma, G., and Lee, S.S. (2021). Therapeutic advances of miRNAs: A preclinical and clinical update. J. Adv. Res. 28: 127–138.

      20 Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., Li, Q., Li, X., Wang, W., Zhang, Y., Wang, J., Jiang, X., Xiang, Y., Xu, C., Zheng, P., Zhang, J., Li, R., Zhang, H., Shang, X., Gong, T., Ning, G., Wang, J., Zen, K., Zhang, J., and Zhang, C.Y. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18: 997–1006.

      21 Chevillet, J.R., Kang, Q., Ruf, I.K., Briggs, H.A., Vojtech, L.N., Hughes, S.M., Cheng, H.H., Arroyo, J.D., Meredith, E.K., Gallichotte, E.N., Pogosova-Agadjanyan, E.L., Morrissey, C., Stirewalt, D.L., Hladik, F., Yu, E.Y., Higano, C.S., and Tewari, M. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc. Natl. Acad. Sci. USA 111: 14888–14893.

      22 Chorley, B.N., Atabakhsh, E., Doran, G., Gautier, J.C., Ellinger-Ziegelbauer, H., Jackson, D., Sharapova, T., Yuen, P.S.T., Church, R.J., Couttet, P., Froetschl, R., Mcduffie, J., Martinez, V., Pande, P., Peel, L., Rafferty, C., Simutis, F.J., and Harrill, A.H. (2021a). Methodological considerations for measuring biofluid-based microRNA biomarkers. Crit. Rev. Toxicol. 51 (3): 264–282264–282.

      23 Chorley, B.N., Carswell, G.K., Nelson, G., Bhat, V.S., and Wood, C.E. (2020). Early microRNA indicators of PPARalpha pathway activation in the liver. Toxicol. Rep. 7: 805–815.

      24 Chorley, B.N., Ellinger-Ziegelbauer, H., Tackett, M., Simutis, F.J., Harrill, A.H., Mcduffie, J., Atabakhsh, E., Nassirpour, R., Whiteley, L.O., Leonard, J.F., Carswell, G.K., Harpur, E., Chen, C.L., and Gautier, J.C. (2021b). Urinary miRNA biomarkers of drug-induced kidney injury and their site specificity within the nephron. Toxicol. Sci. 180: 1–16.

      25 Church, R.J., Kullak-Ublick, G.A., Aubrecht, J., Bonkovsky, H.L., Chalasani, N., Fontana, R.J., Goepfert, J.C., Hackman, F., King, N.M.P., Kirby, S., Kirby, P., Marcinak, J., Ormarsdottir, S., Schomaker, S.J., Schuppe-koistinen, I., Wolenski, F., Arber, N., Merz, M., Sauer, J.M., Andrade, R.J., Van Bommel, F., Poynard, T., and Watkins, P.B. (2019). Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology 69: 760–773.

      26 Clark, P.M., Loher, P., Quann, K., Brody, J., Londin, E.R., and Rigoutsos, I. (2014). Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types. Sci. Rep. 4: 5947.

      27 Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9 (2): 276.

      28 Costa, C., Teodoro, M., Rugolo, C.A., Alibrando, C., Giambo, F., Briguglio, G., and Fenga, C. (2020). MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicol. Rep. 7: 759–767.

      29 Deng, Q., Huang, S., Zhang, X., Zhang, W., Feng, J., Wang, T., Hu, D., Guan, L., Li, J., Dai, X., Deng, H., Zhang, X., and Wu, T. (2014). Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbons. Environ. Health Perspect. 122: 719–725.

      30 Ding, E., Zhao, Q., Bai, Y., Xu, M., Pan, L., Liu, Q., Wang, B., Song, X., Wang, J., Chen, L., and Zhu, B. (2016). Plasma microRNAs expression profile in female workers occupationally exposed to mercury. J. Thorac. Dis. 8: 833–841.

      31 Dutta, R.K., Chinnapaiyan, S., and Unwalla, H. (2019). Aberrant microRNAomics in pulmonary complications: Implications in lung health and diseases. Mol. Ther. Nucleic Acids 18: 413–431.

      32 Farina, N.H., Wood, M.E., Perrapato, S.D., Francklyn, C.S., Stein, G.S., Stein, J.L., and Lian, J.B. (2014). Standardizing analysis of circulating microRNA: Clinical and biological relevance. J. Cell. Biochem. 115: 805–811.

      33 Finicelli, M., Squillaro, T., Galderisi, U., and Peluso, G. (2020). Micro-RNAs: Crossroads between the exposure to environmental particulate pollution and the obstructive pulmonary